Back to back announcements of good news.
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest!
scynexis.com/news-media/press-releases/detail/313/scynexis-announces-3-million-national-institutes-of-health
scynexis.com/news-media/press-releases/detail/314/scynexis-announces-fda-approval-of-second-indication-for
(NOTE: NOT ADVICE IN ANYWAY!! JUST FOOD FOR THOUGHT AND DISCUSSION!!)
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.
면책사항
해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.